SIBO, IMO, SIFO & ISO: Symptoms, Tests & Treatment

Bloating, abdominal pain, constipation or diarrhea that simply won’t go away — despite trying diets, probiotics and multiple practitioners. If this sounds familiar, you may be dealing with one of the most commonly missed gut imbalances: bacterial or microbial overgrowth.

Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), Intestinal Sulfide Overproduction (ISO) and Small Intestinal Fungal Overgrowth (SIFO) are distinct conditions that share overlapping symptoms — and are frequently misdiagnosed or incompletely treated because most practitioners only test for one gas at a time.

In this guide you’ll learn exactly what each condition is, how they differ, which tests identify them, and what a root-cause functional medicine approach to treatment actually looks like.

SIBO, IMO, ISO & SIFO: Key Differences at a Glance

	SIBO	IMO	ISO	SIFO
Full name	Small Intestinal Bacterial Overgrowth	Intestinal Methanogen Overgrowth	Intestinal Sulfide Overproduction	Small Intestinal Fungal Overgrowth
Organism	Bacteria	Archaea	Sulfur-reducing bacteria	Fungi (mainly Candida)
Gas produced	Hydrogen (H2)	Methane (CH4)	Hydrogen sulfide (H2S)	None
Key symptom	Bloating, gas	Constipation	Diarrhea	Bloating, brain fog
IBS type	IBS-D / IBS-M	IBS-C / IBS-M	IBS-D / IBS-M	IBS-D / IBS-M
Breath test	Hydrogen breath test	Methane breath test	H2S breath test (4-gas)	Not detected by breath test
Main diet	Low-FODMAP	Low-FODMAP	Low-sulfur diet	Low-sugar diet

Note: Many patients have more than one type simultaneously — this is why testing all gases at once is essential.

SIBO

SIBO, or small intestinal bacterial overgrowth, is when there are too many bacteria in the small intestine, which causes bothersome and often painful gastrointestinal symptoms. The small intestine usually has fewer bacteria than the colon. When there are too many bacteria in the small intestine, it disrupts the normal balance in the gut microbiome, which causes the symptoms of SIBO.

SIBO Symptoms

Patients with SIBO often experience the following symptoms one or more times a week for at least four weeks:

• Bloating
• Distension
• Abdominal pain
• Gas 
• Flatulence
• Diarrhea
• Constipation

These symptoms can look like other illnesses. The most common symptom reported by patients with SIBO is bloating, often after eating.

What Causes SIBO

SIBO can be a tricky result of a number of different medications and conditions. Patients with irritable bowel syndrome (IBS) and suspected motility disorders are at a higher risk of developing SIBO. Many people don’t know that up to 80% of IBS patients could also have SIBO.

Other patients at risk may have experienced:

• Structural damage, injury, or defects in the small intestine
• Diabetes
• Radiation therapy
• Diverticulosis
• Intestinal lymphoma
• Crohn’s disease 
• Scleroderma
• Gastric surgery (obesity or ulcers)
• Fistula 

Some surgeries can cause SIBO because food and waste can linger in the intestines due to impaired motility from the surgery. This means that there is now more food and waste for the bacteria in the gut to feed on, which causes them to colonize and multiply, resulting in bacterial overgrowth.

Which Gas Indicates SIBO

Some bacteria in the small bowel can produce too much hydrogen (H2). If you have too much hydrogen in your breath, it could mean you have SIBO. The hydrogen breath test is a simple, noninvasive method used to diagnose SIBO by measuring hydrogen gas levels in your breath

IMO

Intestinal methanogenic overgrowth, or IMO, is when there’s an overgrowth of methane-producing archaea in the small and large intestines. This condition was previously called “methane SIBO,” but that term isn’t quite accurate. Methanogens aren’t bacteria (the “B” in SIBO), they’re archaea, which are a group of single-celled organisms lacking a defined nucleus. It’s also possible for these methanogens to overgrow in the colon, not just the small intestine (the “SI” in SIBO).

IMO Symptoms

Patients with IMO experience symptoms similar to SIBO, including abdominal pain, bloating, gas, distension, flatulence, and especially constipation. The level of methane measured by a breath test correlates with the severity of constipation. These symptoms are usually experienced once a week or more for at least four weeks. IMO also has a lot in common with IBS-C (constipation-predominant irritable bowel syndrome) and IBS-M (mixed-diarrhea/constipation irritable bowel syndrome).

What Causes ΙΜΟ

IMO develops when methane-producing archaea — primarily Methanobrevibacter smithii — overgrow in the small and/or large intestine. Unlike SIBO, which is confined to the small intestine, IMO can affect the entire gut, which is one reason it tends to be more stubborn to treat.

Key contributing factors include:

• Impaired motility — a slow migrating motor complex (MMC) allows archaea to accumulate rather than being swept through the gut
• Previous antibiotic use — disrupts the bacterial balance that normally keeps archaea in check
• High-carbohydrate or high-fiber diet — feeds the fermentation process that produces hydrogen, which archaea then consume to produce methane
• Prior SIBO — archaea consume the hydrogen produced by SIBO bacteria, which is why IMO and SIBO frequently coexist
• Low stomach acid — reduces the gut’s natural defence against microbial overgrowth
• Hypothyroidism — slows gut motility, creating an environment where archaea thrive
• Chronic stress — dysregulates the gut-brain axis and impairs MMC function

Because methane gas itself slows gut motility, IMO creates a self-perpetuating cycle: the more methane produced, the slower the gut moves, and the more archaea can grow. This is why constipation is so dominant in IMO — and why treating motility is essential alongside antimicrobial treatment.

Which Gas Indicates IMO

Methane is produced when archaea consume hydrogen. If you have elevated levels of methane (CH4), as measured by a breath test, it’s likely you have IMO. A positive methane breath test is associated with constipation, and the level of methane measured correlates with the severity of constipation.

ISO — Intestinal Sulfide Overproduction

Intestinal Sulfide Overproduction (ISO) occurs when sulfur-reducing bacteria in the gut produce excessive amounts of hydrogen sulfide (H2S) gas. Until recently, ISO was impossible to diagnose because standard breath tests only measured hydrogen and methane. The introduction of 4-gas breath testing has changed this — we can now measure hydrogen sulfide directly, revealing a condition that was previously invisible.

ISO Symptoms

Patients with ISO share many symptoms with SIBO and IMO, but the pattern is distinct:

• Diarrhea (often the dominant symptom)
• Bloating and abdominal pain
• Gas with a distinctive sulfur or “rotten egg” odour
• Flatulence
• Nausea
• Brain fog

The level of hydrogen sulfide measured on a breath test tends to correlate directly with the severity of diarrhea. ISO has strong overlap with IBS-D (diarrhea-predominant IBS) and IBS-M (mixed type).

What Causes ISO

Hydrogen sulfide is produced when sulfur-reducing bacteria consume hydrogen — the same hydrogen produced by fermenting bacteria in SIBO. This is why SIBO and ISO frequently coexist, and why treating SIBO alone often doesn’t fully resolve symptoms when ISO is also present.

Key contributing factors include:

• Impaired motility, which allows bacteria to accumulate
• High dietary sulfur intake (eggs, meat, cruciferous vegetables, dairy, garlic, onions)
• Dysbiosis that favours sulfur-reducing bacteria
• Low molybdenum or bismuth levels — both help neutralise hydrogen sulfide

Which Gas Indicates ISO

A positive hydrogen sulfide (H2S) result on a 4-gas breath test indicates ISO. Standard 2-gas tests (measuring only H2 and CH4) will miss this entirely — one of the most common reasons patients are told their breath test is “normal” while still suffering symptoms.

SIFO

While this article primarily focuses on SIBO (Small Intestinal Bacterial Overgrowth), IMO (Intestinal Methanogen Overgrowth), and ISO (excess hydrogen sulfide) it’s important to also mention SIFO (Small Intestinal Fungal Overgrowth). Like SIBO and IMO, SIFO occurs when the small intestine is overrun by microbes—in this case, fungi, most commonly Candida. Though often overlooked, SIFO can contribute to similar gastrointestinal symptoms, such as bloating, abdominal pain, and diarrhea, and is a significant condition in the context of gut imbalances.

SIFO Symptoms

Patients with SIFO often experience symptoms that overlap with those of SIBO, including:

• Bloating
• Abdominal pain
• Gas and flatulence
• Diarrhea or constipation
• Unexplained fatigue or brain fog

What Causes SIFO?

SIFO is typically triggered by an imbalance in the gut microbiome due to factors like:

• Prolonged antibiotic use, which disrupts normal gut flora
• A high-sugar diet, which fosters fungal growth
• Compromised immune systems, as seen in conditions like diabetes or autoimmune diseases

Individuals with a history of antibiotic overuse, high-sugar consumption, or weakened immune function are at higher risk for SIFO.

How is SIFO Diagnosed?

Diagnosing SIFO can be tricky because its symptoms often mimic those of SIBO, IBS, and other gut conditions. However, some of the best methods for diagnosing SIFO include:

• A stool test to identify fungal overgrowth
• Endoscopy with cultures (though this is invasive and not commonly used)

Why Mention SIFO?

While this article focuses on SIBO, IMO, and ISO, it’s crucial to recognize that SIFO can also contribute to gut imbalance and may be misdiagnosed as another condition. By understanding the full spectrum of small intestinal microbial overgrowths, including SIFO, you can more accurately pinpoint the root causes of your symptoms and pursue the right treatment.

If you’re experiencing any of these symptoms, don’t wait. Book Your Health Strategy Call today to discuss your symptoms and get guidance on next steps.

Hydrogen, Methane and Hydrogen Sulfide Do Not Act Independently

Hydrogen (H2), methane (CH4), and hydrogen sulfide (H2S) interact in a complex way. Hydrogen is produced by fermenting bacteria, but it’s also consumed by other organisms, which results in the production of other gases, including methane and hydrogen sulfide.

There’s a balance-counterbalance effect between methane and hydrogen sulfide, which shows how microbes in the microbiome depend on each other biochemically. These findings are important because they show that measuring only one or two of the three main fermented gases isn’t enough.

New ICD-10 Codes for SIBO/IMO – What Does This Mean for You?

Introduced in the US ICD-10-CM update that took effect on October 1, 2023, these codes gave SIBO, IMO and SIFO formal diagnostic recognition for the first time. They’re part of the US clinical version of ICD-10 (ICD-10-CM), so if you’re outside the US your national coding system may not yet list these exact K63.82 subcodes — ask your local provider which codes apply where you are.

Here are the new codes:

• K63.82 – Intestinal Microbial Overgrowth
• K63.821 – Small Intestinal Bacterial Overgrowth (SIBO)
• K63.8211 – Hydrogen-Subtype (Hydrogen SIBO)
• K63.8212 – Hydrogen Sulfide-Subtype (Hydrogen Sulfide SIBO)
• K63.8219 – Unspecified
• K63.822 – Small Intestinal Fungal Overgrowth (SIFO)
• K63.829 – Intestinal Methanogen Overgrowth, Unspecified (IMO / Methane SIBO)

What Does This Mean?

The International Classification of Diseases (ICD-10) system is used by physicians to classify and code all diagnoses. With dedicated ICD-10 codes, the healthcare community can now better track and analyze conditions like SIBO and IMO, improving diagnosis, treatment, and overall quality of care.

For more information on these codes, visit the official ICD-10 Codes Page.

This official recognition not only provides a clear medical pathway for diagnosis and treatment but also means insurance companies can now cover treatments for these conditions, improving access to care.

Why is This Important for You?

• Better Diagnosis: With specific codes, doctors can easily identify and track SIBO and IMO cases.
• Improved Data Tracking: It will be easier to measure treatment success and improve the quality of care for patients.
• Increased Legitimacy: With these conditions recognized in the ICD-10 system, they will be researched more, leading to better treatments.

Which Tests We Use

FoodMarble Aire 2

In the past, we used the standard breath tests, which need to be repeated at least once at the beginning to diagnose SIBO/IMO and once after treatment to see the results. As the cost and the practicality of these tests didn’t work for our patients, we ended up using the FoodMarble Aire 2 exclusively.

The FoodMarble Aire 2 is a small, portable device that connects to your phone. You buy it once (it costs about the same as a breath test), and you can use it as many times as you want to instantly and easily measure the methane and hydrogen in your breath. We usually choose the 3-hour lactulose test with the Aire 2.

Because the Aire 2 measures only hydrogen and methane, when a patient’s pattern points to hydrogen sulfide (ISO) we add a breath test that also measures H2S — such as trio-smart — so nothing is missed.

You can see more about how it works here: https://foodmarble.com/how-it-works-sibo-tracking/

If you want to get the FoodMarble Aire 2 with a 15% discount you can email info@tsintavismed.com with the subject FoodMarble and we’ll direct you or just click here.

Comprehensive Stool Analysis

Beyond breath testing, there are cases where a deeper analysis of gut health is necessary to fully understand a patient’s condition.

That’s why, for our patients both in Greece and internationally, we often recommend GI-MAP, GI Effects, or GI 360, which provide a comprehensive analysis of the gut microbiome, detect potential pathogens, and assess gut inflammation levels. These tests can be particularly useful when breath test results are inconclusive or when symptoms persist despite treatment.

SIBO, IMO and ISO Treatment

If you’re looking to manage small intestinal bacterial overgrowth (SIBO), intestinal methanogen overgrowth (IMO), and excess hydrogen sulfide (ISO), it’s important to take a holistic approach that incorporates dietary changes, supplementation, and lifestyle modifications.

Diet

Low-FODMAP (preferred)

• What it is: The low FODMAPs diet is all about cutting out foods that are high in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. These include certain grains, vegetables, fruits, and dairy products.
• Benefits: reduces fermentation in the intestine, reducing bloating and gas.

Specific carbohydrate diet (SCD) or the GAPS diet

• What it is: These diets focus on removing complex carbohydrates, working similarly to the low-FODMAP diet by starving harmful bacteria in the small intestine.
• Benefits: helps to reduce bacterial overgrowth.

Low sulfur diet (mainly for excessive H2S)

• What it is: A diet with limited intake of high-sulfur foods. These include cruciferous vegetables, dairy products, eggs, garlic and onions.
• Benefits: reduces the production of hydrogen sulfide.

Elemental diet

• What it is: The elemental diet is all about simple nutrients, usually in powdered supplement form. They’re absorbed directly from the gut into the bloodstream, bypassing fermentation of microbes. This diet provides all the necessary nutrients in an easily absorbed form, minimizing the work the gut has to do.
• Benefits: Highly effective in difficult cases of overgrowth and dysbiosis due to the limited residue, allowing the gut to rest and heal.

Antibiotics

Johns Hopkins Medicine suggests that antibiotics can quickly reduce small intestinal bacterial overgrowth. We don’t usually rely on antibiotics, but if they’re appropriate for you, that decision should be guided by your doctor. The most common ones are:

• Rifaximin: Particularly effective for SIBO, as it is not absorbed and acts locally in the gut without systemic effects.
• Neomycin or metronidazole: often used in combination with Rifaximin and are particularly effective for the treatment of IMO.

Supplements

• Anti-microbial herbs: We often use herbal antimicrobials such as oregano oil, berberine and garlic extract or a combination of all of them like biocidin with very good results.
• Peptic enzymes: Often necessary to help break down food and absorb nutrients. They help in relieving digestive discomfort.
• Hydrochloric acid (HCl): HCl can help improve levels of acid in the stomach, which is vital for proper digestion and for preventing bacteria from entering the small intestine from the stomach. It therefore enhances protein digestion and reduces bacterial overgrowth by creating an acidic environment that is inhospitable to pathogenic bacteria.
• Bile acids (ox bile): Particularly beneficial for people who have had their gallbladder removed or who suffer from bile acid deficiency. They help in the emulsification and breakdown of dietary fats and help regulate the flora of the small intestine.
• Prokinetics: Necessary to maintain bowel motility after treatment with antibiotics or herbal antimicrobials to prevent recurrence of SIBO. They increase the function of the migratory motor complex (MMC), helping to remove food debris and bacteria from the gut. The best known herbal option is ginger.
• Probiotics: The use of probiotics leads to controversial results and sometimes worsening of symptoms. It’s something we usually use after resolving microbial overgrowth with s. boulardii and soil-based probiotics being the first choice.
• Omega-3 fatty acids and curcumin: Many times useful for reducing inflammation of the gut which is caused by and contributes to intestinal dysbiosis.
• Glutamine: Necessary to improve the intestinal barrier and reduce the entry of microbes and food debris into the systemic circulation.

Lifestyle and Helpful Practices

• Stimulation of the vagus nerve: Gargling and singing are 2 easy ways that can stimulate the vagus nerve, which plays a key role in controlling MMC and overall bowel motility. Two tools we commonly use with our non-sensitive patients are the Pulsetto or the Nurosym, two transcutaneous vagus nerve stimulation (tVNS) devices.
• Managing stress: Yoga, meditation, deep breathing and/or use of Pulsetto/Nurosym can improve vagus nerve and adrenal function and reduce stress, which negatively affects gut health and immune system health and motility.
• Physical activity: Regular, moderate-intensity exercise can improve overall mobility and bowel health without putting undue stress on the body.
• Quality sleep: Getting enough quality sleep helps regulate the body’s natural rhythms, supporting gut health and reducing stress and inflammation.

Disclosure: Panagiotis Tsintavis has an affiliate relationship with Pulsetto and Nurosym. We only recommend products we have used and evaluated clinically

Frequently Asked Questions

Conclusions

Small intestinal bacterial overgrowth (SIBO), intestinal methanogen overgrowth (IMO) and excess hydrogen sulfide (ISO) are complex conditions that affect the gut microbiome, leading to symptoms like bloating, diarrhea, abdominal pain and malabsorption of nutrients.

The right treatment for each person must be tailored to their specific symptoms and medical history. It’s important to work with a trained healthcare professional to make sure the right steps are taken to ensure an effective yet safe treatment plan. Nutrition, supplement selection and use and lifestyle changes play a big part in managing symptoms and preventing relapse.

Why Patients Seek SIBO Expertise Internationally

SIBO is complex, and persistent or recurrent cases often require looking beyond bacterial overgrowth alone. Our international patients consistently report that previous treatments focused on bacterial eradication without addressing:

• Underlying motility disorders that allow re-growth
• Immune dysfunction that fails to control bacterial populations
• Nutritional deficiencies that perpetuate the cycle
• Nervous system dysregulation affecting gut function

This systemic approach is why patients achieve lasting SIBO resolution rather than recurring episodes.

If you suspect you have SIBO, IMO, ISO or SIFO Book Your Health Strategy Call and take the first step toward a healthier gut!

References

1. Pimentel, M., Saad, R., Long, M., & Rao, S. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. The American Journal of Gastroenterology, 2020. https://pubmed.ncbi.nlm.nih.gov/32023228/
2. Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. American Journal of Gastroenterology, 2017. https://pubmed.ncbi.nlm.nih.gov/28323273/
3. Lacy, B., Pimentel, M., Brenner, D., Chey, W., Keefer, L., Long, M., & Moshiree, B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. The American Journal of Gastroenterology, 2021.
4. Pimentel, M., Hosseini, A., Chang, C., Mathur, R., Rashid, M., Sedighi, R., Fowler, H., Torosyan, J., Wang, J., & Rezaie, A. Exhaled Hydrogen Sulfide Is Increased in Patients With Diarrhea: Results of a Novel Collection and Breath Testing Device. AGA Abstracts, 2021.
5. Singer-Englar, T., Rezaie, A., Gupta, K., Pichetshote, N., Sedighi, R., Lin, E., Chua, K., & Pimentel, M. Competitive Hydrogen Gas Utilization by Methane- and Hydrogen Sulfide-Producing Microorganisms and Associated Symptoms: Results of a Novel 4-Gas Breath Test Machine. AGA Abstracts, 2021.
6. Pimentel, M., Mathur, R., & Chang, C. Gas and the Microbiome. Current Gastroenterology, 2013. https://www.researchgate.net/publication/258036823_Gas_and_the_Microbiome
7. Singer-Englar, T., Rezaie, A., Gupta, K., Pichetshote, N., Sedighi, R., Lin, E., Chua, K., & Pimentel, M. Validation of a 4-Gas Device for Breath Testing in the Determination of Small Intestinal Bacterial Overgrowth. AGA Abstracts, 2018.
8. Quigley, E. M., & Quera, R. (2016). Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics. Gastroenterology & Hepatology, 2(2), 104-115.
9. Ghoshal, U. C., Shukla, R., & Ghoshal, U. (2017). Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders. Gastroenterology Clinics of North America, 46(1), 103-120. https://pubmed.ncbi.nlm.nih.gov/28164845/
10. Pimentel, M. (2006). A New IBS Solution: Bacteria-The Missing Link in Treating Irritable Bowel Syndrome. Health Point Press.
11. Siebecker, A., & Sandberg-Lewis, S. (2013). SIBO: Dysbiosis Has A New Name. Townsend Letter, 359, 16-20.
12. Dukowicz, A. C., Lacy, B. E., & Levine, G. M. (2007). Small Intestinal Bacterial Overgrowth: A Comprehensive Review. Gastroenterology & Hepatology, 3(2), 112-122.
13. Triantafyllou, K., Chang, C., & Pimentel, M. (2014). Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients with Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease. Arthritis & Rheumatology, 66(1), 128-139.